Esophageal carcinosarcoma is a rare malignant esophageal neoplasm consisting of both carcinomatous and sarcomatous elements, with an incidence of 0.5%. There have been only a few case reports of carcinosarcoma and squamous cell carcinoma coexisting in the esophagus. However, all of these are cases of synchronous or metachronous development of carcinosarcoma after chemoradiotherapy in patients of esophageal squamous cell carcinoma. A 53-year-old man underwent esophagogastroduodenoscopy because of chest pain for several months. Endoscopic examination revealed a huge pedunculated esophageal polypoid mass. Endoscopic submucosal dissection (ESD) was performed and histopathologic examination confirmed spindle cell carcinoma (carcinosarcoma). He refused additional esophagectomy. After 21 months, third follow-up endoscopy showed poorly-demarcated flat, faint discolored lesions at different location from the previous ESD site and endoscopic biopsies confirmed squamous cell carcinoma. To the best of our knowledge, this is the first case of metachronous development of esophageal squamous cell carcinoma in a patient with esophageal carcinosarcoma. (Korean J Gastroenterol 2014;64:364-369) 
INTRODUCTION
Carcinosarcoma of the esophagus is a rare malignant neoplasm consisting of both carcinomatous and sarcomatous elements. Its reported incidence is approximately 0.5% of all esophageal neoplasms. 1 There have been only a few case reports on development of both esophageal carcinosarcoma and squamous cell carcinomas in a patient, all of which were cases of synchronous or metachronous development of carcinosarcoma after chemoradiotherapy in patients of esophageal squamous cell carcinoma. There were no reports on development of esophageal squamous cell carcinoma following carcinosarcoma. In most cases involving development of esophageal carcinosarcoma following squamous cell carcinoma, it has been suggested that the sarcomatous element of esophageal carcinosarcoma generally results from differentiation of carcinoma cells into mesenchymal tumor cells. 2 In contrast, in the histogenesis of squamous cell carcinoma from carcinosarcoma, it is unclear whether both of them have a common clonal origin or not. Here, we present a case of metachronous development of esophageal squamous cell carcinoma in a patient who had undergone endoscopic re- 
CASE REPORT
A 53-year-old man presented to our hospital complaining of epigastric pain for several months. He was diagnosed with hepatitis B associated liver cirrhosis 10 years ago and underwent endoscopic variceal ligation twice three years ago. He had smoked one-third pack of cigarettes a day and drank heavily for 30 years but had stopped binge drinking three years ago.
An endoscopic examination revealed a huge pedunculated esophageal polyp, polyp stalk originating at 25 cm from the upper incisors. The polyp head extended down to 33 cm from the upper incisors and was almost filling the lumen (Fig. 1 ).
The endoscopic biopsies showed some atypical spindle cells, therefore, spindle cell carcinoma or other undifferentiated carcinoma was suspected. A CT scan of the chest and PET-CT were negative for metastasis. Endoscopic submucosal dissection (ESD) was performed. The size of the resected specimen was 4.2×3.0×2.5 cm and the histopathologic examination confirmed spindle cell carcinoma (carcinosarcoma) with more than seven mitoses per high power field (HPF) (Fig. 2) .
Immunohistochemically, the spindle-shaped sarcomatous cells showed negative reaction to cytokeratin, S-100 protein, 
DISCUSSION
The current case was the metachronous development of squamous cell carcinoma following carcinosarcoma of the esophagus in a patient on the basis of histologic evidence.
There have been several case reports on synchronous carcinosarcoma and squamous cell carcinoma in the esophagus, [3] [4] [5] and a case report of esophageal carcinosarcoma arising from squamous cell carcinoma after chemoradiation. 6 In a study with Taiwanese patients, Kuo et al. 7 reported that approximately 33% (4/12) of carcinosarcoma had previous head and neck squamous cell carcinoma that occurred metachronously. However, there has been no previous report on metachronous development of esophageal squamous cell carcinoma in a patient with carcinosarcoma.
Like squamous cell carcinoma of the esophagus, esophageal carcinosarcoma occurs most often in middle-aged men with a history of smoking or drinking or both. 8 The current patient has been a heavy drinker and smoker, and did not have previous history of any other malignancy before diagnosis of esophageal carcinosarcoma.
Carcinosarcoma of the esophagus, also termed sarcomatoid carcinoma, pseudosarcoma, spindle cell carcinoma, or polypoid carcinoma, is an unusual malignant tumor of the esophagus, consisting of both carcinomatous and sarcomatous components. The various terms in use reflect the uncertain pathogenesis of this tumor. 9 Chino et al. 10 reported that the carcinomatous component was differentiated squamous cell carcinoma and the sarcomatous component was spindle cell carcinoma. Histological cell (so-called carcinosarcoma), in other words, the sarcomatous components are considered to result from metaplasia of carcinoma cells. 9 This theory is supported by the frequent finding of a transition zone between the two cell populations and identical genetic alterations are observed in both components. 11 The second is the collision concept, which hypothesizes that two individual stem cells may undergo malignant transformation (true carcinosarcoma) independently and simultaneously, and are actually separate tumors that have merged. 9 Expression of cytokeratin and vimentin were mutually exclusive in the carcinomatous or sarcomatous elements, which may support the collision concept. The third theory suggests that the spindle cell component is a reaction to the carcinoma. 9 In most cases, the metaplastic concept is generally accepted. In the current case, there was no transition zone between carcinomatous and sarcomatous components and the tumor cells showed an immunochemically negative reaction to cytokeratin and a positive reaction to vimentin. Therefore, the patient was finally diagnosed with true carcinosarcoma.
The clinical presentation of esophageal carcinosarcoma is similar to that of squamous cell carcinoma with dysphagia as the most prominent and frequent symptom. 12 They are typically large (mean, 6-7 cm) and polypoid at presentation. The treatment of esophageal carcinosarcoma did not differ from that of other esophageal malignant lesions. Esophagectomy has traditionally been considered as the first option for esophageal carcinosarcoma patients. 13 With the advances in micro-invasive techniques, endoscopic procedures, including endoscopic polypectomy, endoscopic mucosal resection or ESD, may represent an alternative to esophagectomy for superficial esophageal carcinosarcoma. 15 Chemotherapy and concomitant radiation therapy must also be considered for residual microscopic disease and local control.
Esophageal carcinosarcomas do not necessarily have a better prognosis and some authors showed that there is no significant difference in the 5-year survival rates. 1, 3 In a study with 20 cases of esophageal carcinosarcoma, Iyomasa et al. 1 reported that recurrence due to hematogenous metastasis was more frequent in esophageal carcinosarcoma than esophageal squamous cell carcinoma. They emphasized that radical resection with lymph node dissection was necessary for treatment of carcinosarcoma regardless of the depth of invasion.
In conclusion, this is a first case report of metachronous development of esophageal squamous cell carcinoma following carcinosarcoma in a patient. The clinicopathological characteristics and histogenesis of both tumors are not clearly known; therefore, further molecular studies and more cases are needed.
